Patient Guide: A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 95 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06834360
Status: 🟢 Enrolling Now
Condition: Chronic Rhinosinusitis With Nasal Polyps
Phase: PHASE3

Where You Can Participate

This study is available at 95 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Lafayette, California
  • • Los Angeles, California
  • • And 92 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps - Join Clinical Trial NCTNCT06834360

How to Join This Clinical Trial - NCTNCT06834360

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Rhinosinusitis With Nasal Polyps. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Rhinosinusitis With Nasal Polyps. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Rhinosinusitis With Nasal Polyps
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06834360 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 95 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35244 - United States

Status: RECRUITING

Clinical Research Site

Lafayette, California 70508 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90048 - United States

Status: RECRUITING

Clinical Research Site

Napa, California 94558 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 91942 - United States

Status: RECRUITING

Clinical Research Site

New Port Richey, Florida 34653 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60607 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45219 - United States

Status: RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73120 - United States

Status: RECRUITING

And 85 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Rhinosinusitis With Nasal Polyps:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships